Active — Not RecruitingNot Applicable

A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors

United States72 participantsStarted 2019-04-01

Plain-language summary

This research study aims to explore the feasibility and acceptability of an adapted resiliency group program, called the Relaxation Response Resiliency Program (3RP-AYA), to reduce stress and promote stress-management among adolescents and young adults who have completed treatment for cancer.

Who can participate

Age range16 Years – 29 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with any cancer between ages 14 and 29 * Completed cancer treatment within the past 5 years * At least 16 years of age at time of enrollment Exclusion Criteria: * Unwilling or unable to participate in the study * Unable to speak or read English * Is medically or otherwise unable to participate (as determined by a physician or study PI) * Unwilling or unable to participate in study sessions delivered via the Partners Telehealth videoconferencing software * Participation in a focus group during Phase 1 (DF/HCC 17-315)

What they're measuring

3RP-AYA Feasibility: Percent of Identified Eligibles Who Enroll

Timeframe: Post-treatment completion (treatment is approximately 8 weeks)

3RP-AYA Feasibility: Proportion of Participants Completing the 3RP-AYA Program

Timeframe: Post-treatment completion (treatment is approximately 8 weeks)

3RP-AYA Acceptability: Five Questions

Timeframe: Post-treatment completion (treatment is approximately 8 weeks)

Trial details

NCT IDNCT03768336

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-01

Results submitted2022-09-10

View on ClinicalTrials.gov More Cancer trials